Published in AIDS Weekly, May 14th, 2001
"Allogeneic blood transfusions have immunomodulatory effects and have been associated with activation of [HIV] and cytomegalovirus (CMV) in vitro and of HIV in small pilot studies," A.C. Collier and colleagues explained in the Journal of the American Medical Association. "Retrospective studies suggest that transfusions adversely affect the clinical course of HIV."
After evaluating the usefulness of leukocyte reduction in attenuating this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.